CHILDRENS ALLEGRA ALLERGY- fexofenadine hydrochloride suspension 
Chattem, Inc.

----------

Childrens Allegra Allergy Oral Suspension

Drug Facts

Active ingredient

(in each 5 mL)

Fexofenadine HCI 30 mg

Purpose

Antihistamine

Uses

temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:

Warnings

Do not use

if you have ever had an allergic reaction to this product or any of its ingredients.

Ask a doctor before use if you have

kidney disease. Your doctor should determine if you need a different dose.

When using this product

  • do not take more than directed
  • do not take at the same time as aluminum or magnesium antacids
  • do not take with fruit juices (see Directions)

Stop use and ask a doctor if

an allergic reaction to this product occurs. Seek medical help right away.

If pregnant or breast-feeding,

ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

adults and children 12 years of age and overtake 10 mL every 12 hours; do not take more than 20 mL in 24 hours
children 2 to under 12 years of agetake 5 mL every 12 hours; do not take more than 10 mL in 24 hours
children under 2 years of ageask a doctor
adults 65 years of age and olderask a doctor
consumers with kidney diseaseask a doctor

Note: mL = milliliters

Other information

Inactive ingredients

edetate disodium, flavor, poloxamer 407, potassium sorbate, propylene glycol, purified water, sodium phosphate dibasic heptahydrate, sodium phosphate monobasic monohydrate, sucrose, titanium dioxide, xanthan gum, xylitol

Questions or comments?

call toll-free 1-800-844-2798 

PRINCIPAL DISPLAY PANEL

NDC 41167-4244-4
Children’s
Allegra®
ALLERGY
fexofenadine HCI
oral suspension
12 HR
30 mg/5 ml antihistamine

NDC 41167-4244-4
Children’s 
Allegra® 
ALLERGY
fexofenadine HCI 
oral suspension 
12 HR
30 mg/5 ml antihistamine

PRINCIPAL DISPLAY PANEL

NDC 41167-4246-4
Children’s
Allegra®
ALLERGY
fexofenadine HCI
oral suspension
12 HR
30 mg/5 ml antihistamine

NDC 41167-4246-4
Children’s 
Allegra® 
ALLERGY
fexofenadine HCI 
oral suspension 
12 HR
30 mg/5 ml antihistamine

CHILDRENS ALLEGRA ALLERGY 
fexofenadine hydrochloride suspension
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:41167-4244
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
FEXOFENADINE HYDROCHLORIDE (UNII: 2S068B75ZU) (FEXOFENADINE - UNII:E6582LOH6V) FEXOFENADINE HYDROCHLORIDE30 mg  in 5 mL
Inactive Ingredients
Ingredient NameStrength
EDETATE DISODIUM (UNII: 7FLD91C86K)  
POLOXAMER 407 (UNII: TUF2IVW3M2)  
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
WATER (UNII: 059QF0KO0R)  
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE (UNII: 70WT22SF4B)  
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE (UNII: 593YOG76RN)  
SUCROSE (UNII: C151H8M554)  
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
XANTHAN GUM (UNII: TTV12P4NEE)  
POTASSIUM SORBATE (UNII: 1VPU26JZZ4)  
XYLITOL (UNII: VCQ006KQ1E)  
Product Characteristics
ColorwhiteScore    
ShapeSize
FlavorBERRYImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:41167-4244-41 in 1 CARTON03/03/2011
1120 mL in 1 BOTTLE; Type 0: Not a Combination Product
2NDC:41167-4244-11 in 1 CARTON03/03/2011
2240 mL in 1 BOTTLE; Type 0: Not a Combination Product
3NDC:41167-4244-73 in 1 CELLO PACK03/03/2011
3120 mL in 1 BOTTLE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
NDANDA20137303/03/2011
CHILDRENS ALLEGRA ALLERGY 
fexofenadine hydrochloride suspension
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:41167-4246
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
FEXOFENADINE HYDROCHLORIDE (UNII: 2S068B75ZU) (FEXOFENADINE - UNII:E6582LOH6V) FEXOFENADINE HYDROCHLORIDE30 mg  in 5 mL
Inactive Ingredients
Ingredient NameStrength
EDETATE DISODIUM (UNII: 7FLD91C86K)  
POLOXAMER 407 (UNII: TUF2IVW3M2)  
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
WATER (UNII: 059QF0KO0R)  
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE (UNII: 70WT22SF4B)  
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE (UNII: 593YOG76RN)  
SUCROSE (UNII: C151H8M554)  
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
XANTHAN GUM (UNII: TTV12P4NEE)  
POTASSIUM SORBATE (UNII: 1VPU26JZZ4)  
XYLITOL (UNII: VCQ006KQ1E)  
Product Characteristics
ColorwhiteScore    
ShapeSize
FlavorGRAPEImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:41167-4246-41 in 1 CARTON03/01/2023
1120 mL in 1 BOTTLE; Type 0: Not a Combination Product
2NDC:41167-4246-21 in 1 CARTON03/01/2023
2240 mL in 1 BOTTLE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
NDANDA20137303/03/2011
Labeler - Chattem, Inc. (003336013)

Revised: 10/2024
Document Id: 44d1c575-0058-44c2-b5c4-40750cf8d2d4
Set id: e2bd23c7-dfba-463a-adbe-2183970da740
Version: 26
Effective Time: 20241001
 
Chattem, Inc.